BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3487138)

  • 1. Murine monoclonal antibodies to human factor XI.
    Nishikado H; Komiyama Y; Masuda M; Egawa H; Murata K
    Thromb Res; 1986 Apr; 42(2):225-34. PubMed ID: 3487138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of activation of coagulation factor XI by factor XIIa studied with monoclonal antibodies.
    Akiyama H; Sinha D; Seaman FS; Kirby EP; Walsh PN
    J Clin Invest; 1986 Dec; 78(6):1631-7. PubMed ID: 3491093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of human blood coagulation factor XIa using hybridoma antibodies.
    Sinha D; Koshy A; Seaman FS; Walsh PN
    J Biol Chem; 1985 Sep; 260(19):10714-9. PubMed ID: 3875611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional domains in the heavy-chain region of factor XI: a high molecular weight kininogen-binding site and a substrate-binding site for factor IX.
    Baglia FA; Sinha D; Walsh PN
    Blood; 1989 Jul; 74(1):244-51. PubMed ID: 2665835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
    Griffin JH; Cochrane CG
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the coagulant activity and surface binding of high molecular weight kininogen.
    Colman RW; Silver LD; Purdon AD; Chang JJ; Scott CF
    Trans Assoc Am Physicians; 1984; 97():113-23. PubMed ID: 6336014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amidolytic assay of human factor XI in plasma: comparison with a coagulant assay and a new rapid radioimmunoassay.
    Scott CF; Sinha D; Seaman FS; Walsh PN; Colman RW
    Blood; 1984 Jan; 63(1):42-50. PubMed ID: 6606454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact activation of factor XI.
    Jacobs A; Mannhalter C; Margalit R; Schiffman S
    Br J Haematol; 1981 Sep; 49(1):77-86. PubMed ID: 7272231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies.
    Hock J; Vogel R; Linke RP; Müller-Esterl W
    J Biol Chem; 1990 Jul; 265(20):12005-11. PubMed ID: 1694851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of charged groups in factor XI/XIa activity.
    Morgan K; Schiffman S
    J Biol Chem; 1982 Oct; 257(19):11284-7. PubMed ID: 6981645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIa-alpha 1 antitrypsin complex--elevation in the patients with DIC.
    Nishikado H; Komiyama Y; Masuda M; Egawa H; Murata K
    Thromb Res; 1986 Nov; 44(4):489-501. PubMed ID: 3492061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymes of the contact phase of blood coagulation: kinetics with various chromogenic substrates and a two-substrate assay for the joint estimation of plasma prekallikrein and factor XI.
    Retzios AD; Rosenfeld R; Schiffman S
    J Lab Clin Med; 1988 Nov; 112(5):560-6. PubMed ID: 3263454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate.
    Scott CF; Pixley RA; Colman RW
    Thromb Res; 1987 Dec; 48(6):685-700. PubMed ID: 3501619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface activation of blood coagulation, fibrinolysis and kinin formation.
    Heimark RL; Kurachi K; Fujikawa K; Davie EW
    Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of factor XI in plasma is dependent on factor XII.
    Brunnée T; La Porta C; Reddigari SR; Salerno VM; Kaplan AP; Silverberg M
    Blood; 1993 Feb; 81(3):580-6. PubMed ID: 8427954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI.
    Tait JF; Fujikawa K
    J Biol Chem; 1987 Aug; 262(24):11651-6. PubMed ID: 3650269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a factor IX binding site on the third apple domain of activated factor XI.
    Sun Y; Gailani D
    J Biol Chem; 1996 Nov; 271(46):29023-8. PubMed ID: 8910554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor.
    Silverberg M; Nicoll JE; Kaplan AP
    Thromb Res; 1980 Oct; 20(2):173-89. PubMed ID: 6908319
    [No Abstract]   [Full Text] [Related]  

  • 19. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens.
    Sugi T; McIntyre JA
    J Autoimmun; 2001 Nov; 17(3):207-14. PubMed ID: 11712858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.